KIM STOPCZYNSKI: Open Payments
NPI 1538581558 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,376 in 192 payments from 42 companies in 2025. Trend: 2023 $2,393 · 2024 $3,899 · 2025 $4,376
Food & beverage: $4,376
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $405 |
| Merck Sharp & Dohme LLC | 14 | $317 |
| PFIZER INC. | 13 | $288 |
| E.R. Squibb & Sons, L.L.C. | 15 | $265 |
| Incyte Corporation | 11 | $259 |
| ABBVIE INC. | 9 | $246 |
| AstraZeneca Pharmaceuticals LP | 10 | $233 |
| BeOne Medicines USA, Inc. | 8 | $217 |
| Gilead Sciences, Inc. | 10 | $200 |
| Janssen Biotech, Inc. | 8 | $196 |
Products named: KEYTRUDA, TEVIMBRA, OPDIVO, Enhertu, Trodelvy, KISQALI, Indigo System, Zoladex.
Industry payments across FL — which companies pay providers there.
